Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
about
Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinomaIdentification of a secretory protein c19orf10 activated in hepatocellular carcinoma.The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinomaUtility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control studyGrowth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma.Vitamin K-dependent proteins and hepatocellular carcinoma.Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinomaDiagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.Primary colon cancer with a high serum PIVKA-II levelScreening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.Secondary prevention of hepatocellular carcinoma.Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population.The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection.Should AFP (or any biomarkers) be used for HCC surveillance?Vitamin K contents in liver tissue of hepatocellular carcinoma patients.Des-γ-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma
P2860
Q30244651-49D11C3C-844E-4EB6-A476-A9ECF69BC676Q33752079-EF7004BC-3D49-458A-9377-7CB04183643CQ33762456-43795F3E-9099-4B5E-9004-844DFA3D4DE0Q34577896-2FFD7E0C-DB5B-4658-96C5-BB63F998AA94Q35151800-5D0293CB-9D5A-4959-BCB3-9BFB4FD23F01Q35621312-1B97E296-3FC3-4D18-B9C3-55276465AE61Q35764990-2F14490C-C30D-4DE8-8BB4-A2B0BDBC180DQ35951527-52CB6F08-B1A2-4005-A9C3-12F3CDC2E635Q36200024-B36263EB-7D58-4333-AD46-74852585B69AQ36427203-5AFB3C59-0552-45C2-95FE-F0E301FE7D6FQ36622061-F3966BC6-85B6-41D2-93C8-55C1D6D1B17CQ37577551-864BD129-DADF-4AC5-B863-E5A4B03E3F9EQ37669086-946A55F5-C76B-4DBE-9570-112CDFC7A43BQ38295360-FE3F4D1F-1372-42EE-AF4F-3CBD4A7BA62DQ38704948-0BD8C244-8F90-4D92-AEB1-2A288D34C8CDQ40957774-D0294B8A-49BD-4DE1-B1F8-17896F92C247Q42278956-FD56AC99-F875-4584-AB47-F99A05419264Q45407203-B3D2C7C0-BD63-49EC-8AF5-CF98330972F0Q50223186-DAE6D33E-F5FD-4887-8443-D079853F1C9BQ55286721-E9F64C07-FE94-4650-8EF4-7D870B5CA221Q57763202-368A4F73-3A8E-4969-B6A3-E7901DC4A459
P2860
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@ast
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@en
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@nl
type
label
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@ast
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@en
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@nl
prefLabel
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@ast
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@en
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@nl
P2093
P356
P1433
P1476
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
@en
P2093
P356
10.1002/HEP.1840110321
P407
P577
1990-03-01T00:00:00Z